View in EDS HTML Full Text PDF Full Text

Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma.

Saved in:
Bibliographic Details
Title: Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma.
Authors: Ma'koseh, Mohammad1,2 (AUTHOR), Yaseen, Abeer1 (AUTHOR) AY.14851@KHCC.JO, Abed, Nebras Abu1 (AUTHOR), Shahin, Omar1,2 (AUTHOR), Abufara, Alaa1 (AUTHOR), Halahleh, Khalid1 (AUTHOR), Al-Rwashdeh, Mohammad1 (AUTHOR), Rahman, Zaid Abdel1,2 (AUTHOR), Muqbel, Ro'a3 (AUTHOR), Farfoura, Heba4 (AUTHOR), Al-Ibraheem, Akram5 (AUTHOR), Al-rabi, Kamal1,2 (AUTHOR), Abdel-Razeq, Hikmat1,2 (AUTHOR)
Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10245332
DOI:10.1080/16078454.2025.2515337